Clinical trial
A Single-Center, Study to Evaluate the Safety and Tolerability of Hemoglobin-Based Oxygen Carrier-201 (HBOC 201) in Trauma Subjects. (Phase II - Safety and Tolerability)
NCT00301483 is registered in ClinicalTrials.gov with Biopure Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Center, Study to Evaluate the Safety and Tolerability of Hemoglobin-Based Oxygen Carrier-201 (HBOC 201) in Trauma Subjects. (Phase II - Safety and Tolerability)
- Lead sponsor
- Biopure Corporation
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2004
- Completion date
- December 31, 2008
- Enrollment
- 53 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.